Disitamab vedotin (ADC)

描述	Disitamab vedotin is an ADC consisting of a HER2-directed antibody and Monomethyl auristatin E (MMAE). Disitamab vedotin targets HER2 protein on tumors, recognizes and penetrates cancer cells with high precision, and releases the small molecule cytotoxic drug to kill the cancer cell. The ADC is used for the study of various cancers.
种属反应性	Human
状态	Liquid
浓度	1 mg/ml
纯度	>90% as determined by SEC.
克隆类型	Monoclonal
应用	Research Grade Biosimilar
靶标	HER2
纯化方式	Purified by Ion Exchange Chromatography.
内毒素水平	Please contact with the lab for this information.
稳定性和存储	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
别名	RC48, Aidixi
克隆号	Disitamab vedotin
备注	For research use only. Not suitable for clinical or therapeutic use.

AntibodySystem Laboratories SAS was created in 2019 in France as an independent brand, specializing in the research, development, and production of protein and antibody reagents for the life sciences. We are committed to providing high-quality protein and antibody products to life science researchers worldwide. Our offerings include a variety of antibodies and proteins, such as traditional polyclonal antibodies, housekeeping antibodies, tag antibodies, high-activity proteins, functional antibodies for in vivo studies, low-background flow cytometry antibodies, highly specific nanobodies, specialized small molecule antibodies, phospho-specific antibodies, DNA/RNA antibodies, and PEG antibodies—over ten product lines in total.
AntibodySystem products span research areas including 48 viruses, superbugs, parasites, cancer, Alzheimer's, Parkinson's, allergic and hypersensitivity reactions, immune suppression, and immune activation.